Improving outcomes for people living with certain rare diseases, cancers or neurological conditions
ONCOLOGY
With over 35 years of experience in oncology, Ipsen’s growing portfolio is focused on difficult-to-treat cancers aimed at improving the lives of people with pancreatic cancer, follicular lymphoma, epithelioid sarcoma, as well as gastrointestinal and pancreatic neuroendocrine tumors and carcinoid syndrome.
RARE DISEASE
We continue to evolve and grow our research efforts in the area of rare and ultra-rare disease. Given the limited understanding of these diseases, we are committed to addressing patient needs, from supporting diagnosis to treatment with specific investment in pituitary pathologies, growth disorders, liver disease and ultra-rare bone diseases, including fibrodysplasia ossificans progressiva, commonly known as FOP.
NEUROSCIENCE
People suffering from neurological disorders are in need of treatments, and we’ve become a global leader in creating them through the research, development, manufacturing and commercialization of neurotoxins to help treat certain types of spasticity in adults and children two years and older, and cervical dystonia in adults.